Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2013-12-19

Clinical Trial Update: Cyclosporine and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia [Phase 2]

View source ↗

Summary

Clinical trial update for a Phase 2 study of cyclosporine with combination chemotherapy in relapsed or refractory acute myeloid leukemia; current status is unkn…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CYCLOSPORINE (cyclosporine)

Snippet

Sponsor: University Medical Center Groningen | Conditions: Leukemia | Phase 2 | Status: UNKNOWN